Current and historical gross, operating and net profit margins for GlaxoSmithKline (GSK) over the last 10 years. The current net profit margin for GlaxoSmithKline (GSK) as of March 31, 2018 is 3.5%.
||Large Cap Pharmaceutical
GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.